Literature DB >> 34612153

LncRNA LINC00460 takes a stimulating role on hepatocellular carcinoma stemness property.

Bitao Chen1, Kejun Zhang2, Qinli Han1, Weiwei Zhong1, Jie Yi1, Huiling Zhu1, Shitao Xia1.   

Abstract

Abundant researches have stated that long noncoding RNAs (lncRNAs) are crucial molecules in intricate progression of various cancers in terms of their influence on cell stemness. However, no research has discussed the role of LINC00460 in the stemness of hepatocellular carcinoma (HCC). RT-qPCR and western blot were utilized to respectively examine the RNA and protein levels. Aldehyde dehydrogenase 1 (ALDH1) assays and sphere formation assay were performed to detect cell stemness property in vitro and in vivo subcutaneous xenograft tumor assay was performed to detect tumor growth. Interaction between RNAs was explored by luciferase reporter assays and RNA pull-down assays. Our results showed that LINC00460 was markedly over-expressed in HCC and silencing LINC00460 impaired cell stemness. Additionally, LINC00460 knockdown curbed proliferation, migration, invasion and epithelial-to-mesenchymal transition (EMT) and drove apoptosis of HCC cells. Further, LINC00460 bound to miR-503-5p and miR-654-3p to protect t-complex 1 (TCP1) from being inhibited by miR-503-5p/miR-654-3p. Rescue experiments confirmed the effect of LINC00460/miR-503-5p/miR-654-3p/TCP1 on HCC cell stemness. In conclusion, LINC00460 aggravated cell stemness in HCC via targeting miR-503-5p/miR-654-3p and TCP1, suggesting that LINC00460 may work as a potential signature for cell stemness in HCC.[Figure: see text].

Entities:  

Keywords:  LINC00460; TCP1; hepatocellular carcinoma; miR-503-5p; miR-654-3p; stemness

Mesh:

Substances:

Year:  2021        PMID: 34612153      PMCID: PMC8565821          DOI: 10.1080/15384101.2021.1940627

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   5.173


  23 in total

Review 1.  ceRNA in cancer: possible functions and clinical implications.

Authors:  Xiaolong Qi; Da-Hong Zhang; Nan Wu; Jun-Hua Xiao; Xiang Wang; Wang Ma
Journal:  J Med Genet       Date:  2015-09-10       Impact factor: 6.318

2.  lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling.

Authors:  Runzhou Zhuang; Xuanyu Zhang; Di Lu; Jianguo Wang; Jianyong Zhuo; Xuyong Wei; Qi Ling; Haiyang Xie; Shusen Zheng; Xiao Xu
Journal:  Mol Carcinog       Date:  2018-11-25       Impact factor: 4.784

Review 3.  Screening for hepatocellular carcinoma in high-risk populations.

Authors:  Zoe A Miller; Kyungmouk Steve Lee
Journal:  Clin Imaging       Date:  2015-11-23       Impact factor: 1.605

Review 4.  Cancer cells stemness: A doorstep to targeted therapy.

Authors:  Sahdeo Prasad; Sharavan Ramachandran; Nehal Gupta; Itishree Kaushik; Sanjay K Srivastava
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-02-26       Impact factor: 5.187

5.  Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.

Authors:  Guanming Lu; Yueyong Li; Yanfei Ma; Jinlan Lu; Yongcheng Chen; Qiulan Jiang; Qiang Qin; Lifeng Zhao; Qianfang Huang; Zhizhai Luo; Shiqing Huang; Zhongheng Wei
Journal:  J Exp Clin Cancer Res       Date:  2018-11-27

Review 6.  Hepatocellular carcinoma: From diagnosis to treatment.

Authors:  Miral Sadaria Grandhi; Amy K Kim; Sean M Ronnekleiv-Kelly; Ihab R Kamel; Mounes A Ghasebeh; Timothy M Pawlik
Journal:  Surg Oncol       Date:  2016-03-05       Impact factor: 3.279

7.  LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation.

Authors:  Di Cheng; Junge Deng; Bin Zhang; Xiaoyu He; Zhe Meng; Guolin Li; Huilin Ye; Shangyou Zheng; Lusheng Wei; Xiaogeng Deng; Rufu Chen; Jiajia Zhou
Journal:  EBioMedicine       Date:  2018-09-05       Impact factor: 8.143

8.  Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.

Authors:  Regina Cheuk-Lam Lo; Carmen Oi-Ning Leung; Kristy Kwan-Shuen Chan; Daniel Wai-Hung Ho; Chun-Ming Wong; Terence Kin-Wah Lee; Irene Oi-Lin Ng
Journal:  Cell Death Differ       Date:  2018-02-14       Impact factor: 15.828

9.  A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.

Authors:  Yufeng Wang; Liu Yang; Tianxiang Chen; Xin Liu; Yang Guo; Qiaojuan Zhu; Xiangmin Tong; Wei Yang; Qiuran Xu; Dongsheng Huang; Kangsheng Tu
Journal:  Mol Cancer       Date:  2019-02-19       Impact factor: 27.401

10.  LncRNA PTCSC3 Inhibits Tumor Growth and Cancer Cell Stemness in Gastric Cancer by Interacting with lncRNA Linc-pint.

Authors:  Lei Hong; Haijuan Wang; Junyan Wang; Suju Wei; Fan Zhang; Jing Han; Yan Liu; Minting Ma; Chengyuan Liu; Yu Xu; Da Jiang
Journal:  Cancer Manag Res       Date:  2019-12-11       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.